142 related articles for article (PubMed ID: 19491989)
1. Oculoleptomeningeal amyloidosis in 3 individuals with the transthyretin variant Tyr69His.
Schweitzer K; Ehmann D; Garcia R; Alport E
Can J Ophthalmol; 2009 Jun; 44(3):317-9. PubMed ID: 19491989
[TBL] [Abstract][Full Text] [Related]
2. Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene.
Roe RH; Fisher Y; Eagle RC; Fine HF; Cunningham ET
Ophthalmology; 2007 Nov; 114(11):e33-7. PubMed ID: 17980738
[TBL] [Abstract][Full Text] [Related]
3. Vitreous Amyloidosis: Ocular, Systemic, and Genetic Insights.
Venkatesh P; Selvan H; Singh SB; Gupta D; Kashyap S; Temkar S; Gogia V; Tripathy K; Chawla R; Vohra R
Ophthalmology; 2017 Jul; 124(7):1014-1022. PubMed ID: 28412068
[TBL] [Abstract][Full Text] [Related]
4. Considering amyloidosis in patients with clinically unresponsive vitreous inflammation (Oculoleptomeningeal amyloidosis in 3 individuals with transthyretin variant Tyr69His. Vol. 44[3]).
Roe RH; Cunningham ET
Can J Ophthalmol; 2010 Feb; 45(1):81. PubMed ID: 20130721
[No Abstract] [Full Text] [Related]
5. Immunostaining images of vitreous transthyretin amyloid.
Latasiewicz M; Adan A; Solé M
Can J Ophthalmol; 2015 Oct; 50(5):384-7. PubMed ID: 26455975
[TBL] [Abstract][Full Text] [Related]
6. Oculoleptomeningeal Amyloidosis Secondary to the Rare Transthyretin c.381T>G (p.Ile127Met) Mutation.
Mathieu F; Morgan E; So J; Munoz DG; Mason W; Kongkham P
World Neurosurg; 2018 Mar; 111():190-193. PubMed ID: 29277593
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of vitreous amyloidosis and need of surgical reintervention in Portuguese patients with familial amyloidosis ATTR V30M.
Beirão NM; Matos E; Beirão I; Costa PP; Torres P
Retina; 2011; 31(7):1373-7. PubMed ID: 21358362
[TBL] [Abstract][Full Text] [Related]
8. Transthyretin Ala36Pro mutation in a Chinese pedigree of familial transthyretin amyloidosis with elevated vitreous and serum vascular endothelial growth factor.
Zou X; Dong F; Zhang S; Tian R; Sui R
Exp Eye Res; 2013 May; 110():44-9. PubMed ID: 23438977
[TBL] [Abstract][Full Text] [Related]
9. Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His.
Blevins G; Macaulay R; Harder S; Fladeland D; Yamashita T; Yazaki M; Hamidi Asl K; Benson MD; Donat JR
Neurology; 2003 May; 60(10):1625-30. PubMed ID: 12771253
[TBL] [Abstract][Full Text] [Related]
10. Vitreal deposits in Val71Ala transthyretin amyloidosis.
Suan D; Booth DR; Kennedy IH; Downie J; Earls P; Gottlieb D; Stewart GJ; Lin MW
Intern Med J; 2012 Jan; 42(1):106-8. PubMed ID: 22276564
[No Abstract] [Full Text] [Related]
11. [Transthyretin Arg-83 mutation in vitreous amyloidosis].
Chen L; Lü L; Zhang P; Li Y; Lin J
Yan Ke Xue Bao; 2008 Mar; 24(1):65-7. PubMed ID: 18709962
[TBL] [Abstract][Full Text] [Related]
12. Vitreous involvement as initial presentation of hereditary transthyretin amyloidosis related to the rare TTR Ile107Met (p.Ile127Met) pathogenic variant.
Treviño-Herrera AB; Bustamante-Vargas AP; Lisker-Cervantes A; Ríos Y Valles Valles D; Villanueva-Mendoza C; González-Duarte A; Concha-Del-Río LE
Ophthalmic Genet; 2022 Jun; 43(3):413-419. PubMed ID: 35038954
[TBL] [Abstract][Full Text] [Related]
13. A rare transthyretin mutation (Asp18Glu) associated with vitreous amyloid.
Solano JM; Pulido JS; Salomao DR
Ophthalmic Genet; 2007 Jun; 28(2):73-5. PubMed ID: 17558848
[TBL] [Abstract][Full Text] [Related]
14. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
[TBL] [Abstract][Full Text] [Related]
15. Vitreous amyloidosis in two sisters as the indication of transthyretin-related familial form of systemic amyloidosis among liver transplantation candidates.
Niemczyk R; Brydak-Godowska J; Kecik D; Wagner T; Lewandowski P; Kecik M; Zygier D; Ołdakowska-Jedynak U
Transplant Proc; 2009 Oct; 41(8):3085-7. PubMed ID: 19857683
[TBL] [Abstract][Full Text] [Related]
16. RE-INTERVENTION IN DE NOVO VITREOUS OPACITIES AFTER PARS PLANA VITRECTOMY IN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY TTR VAL30METPORTUGUESE PATIENTS.
Ferreira NN; Cunha Dias DA; Afonso Carvalho RP; Pardal Monteiro Coelho MT
Retin Cases Brief Rep; 2019 Summer; 13(3):273-278. PubMed ID: 28333852
[TBL] [Abstract][Full Text] [Related]
17. Early onset vitreous amyloidosis in familial amyloidotic polyneuropathy with a transthyretin Glu54Gly mutation is associated with elevated vitreous VEGF.
O'Hearn TM; Fawzi A; He S; Rao NA; Lim JI
Br J Ophthalmol; 2007 Dec; 91(12):1607-9. PubMed ID: 17522146
[TBL] [Abstract][Full Text] [Related]
18. Ophthalmic manifestations in a Chinese family with familial amyloid polyneuropathy due to a TTR Gly83Arg mutation.
Liu T; Zhang B; Jin X; Wang W; Lee J; Li J; Yuan H; Cheng X
Eye (Lond); 2014 Jan; 28(1):26-33. PubMed ID: 24113303
[TBL] [Abstract][Full Text] [Related]
19. Unusual Vitreous Opacity in a Chinese Patient.
Yu S; Xu Y; Liang X
JAMA Ophthalmol; 2019 Dec; 137(12):1454-1455. PubMed ID: 31621813
[No Abstract] [Full Text] [Related]
20. Cytodiagnosis and protein typing of amyloid from a vitreous washing: initial diagnostic workup of hereditary amyloidosis.
Coppock JD; Dusenbery AC; Elghawy O; Fellenstein LA; Frierson HF; Shildkrot Y
J Am Soc Cytopathol; 2020; 9(3):173-176. PubMed ID: 32113804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
